Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by SizzlinSteakson Nov 09, 2018 9:37am

91 Views

Post# 28949403

RE:RE:RE:P6

Here is another:

https://www.businessinsider.com/gilead-to-buy-kite-pharma-for-12-billion-a-cancer-immunotherapy-company-2017-8

Gilead buys Kite Pharma for 12 billion

SizzlinSteaks wrote: Yes sir!

It has been discussed on this board several times in the past. Prime example right here.

Pfizer buys Medivation for 14 Billion

Longholder99 wrote: I can't even guess what the returns are going to be on this play when the market grabs on. I see $10-15B buyouts on companies with lesser results on fewer indications. If/when TLT gets into PH2 results and adds GBM and Lung studies. I'm at my limit in making a guess on what the SP will hit. It's what keeps me invested and accumulating.